Atea Pharmaceuticals News

Atea Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-EcoR1 Capital, LLC(6.4%),Oleg Nodelman(6.4%), etc.

Nov 14 10:38 ET

Atea Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(7.839%),Abigail P. Johnson(7.839%)

Nov 12 09:55 ET

Atea Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 7 22:38 ET

Atea Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers

Nov 7 17:08 ET

Atea Pharmaceuticals | 8-K: Atea Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 7 16:33 ET

Atea Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Sommadossi Jean-Pierre

Sep 19 20:05 ET

Atea Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Sep 19 16:26 ET

Atea Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Sep 18 16:13 ET

Atea Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Sep 17 16:20 ET

Atea Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

Aug 7 16:52 ET

Atea Pharmaceuticals | 8-K: Atea Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 7 16:23 ET

Atea Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Duncan Barbara Gayle

Jun 21 18:16 ET

Atea Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director BERGER FRANKLIN M

Jun 21 18:11 ET

Atea Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Adams Jerome M.

Jun 21 18:11 ET

Atea Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Polsky Bruce

Jun 21 18:02 ET

Atea Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Lucidi Bruno

Jun 21 18:02 ET

Atea Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Murphy Polly A.

Jun 21 17:56 ET

Atea Pharmaceuticals | 8-K: Current report

Jun 21 17:26 ET

Atea Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Jun 20 17:37 ET

Atea Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Adams Jerome M.

Jun 18 17:06 ET